Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.758,91
0,05%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Chemgenex Pharmaceuticals Ltd (MM) (CXSP) Chemgenex Pharmaceuticals Ltd (MM) (CXSP) Notizie

CXSP

Chemgenex (CXSP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CXSP
DataOraFonteTitoloSimboloCompagnia
29/06/200915:19Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/06/200918:00Business WirePivotal Study Results: ChemGenex’s Omacetaxine May Provide the First Viable Drug Treatment Option for Patients With a Highl...NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
21/05/200913:00Business WireChemGenex’s Omacetaxine to be Showcased in Three Oral Presentations at EHANASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
15/05/200901:30Business WireChemGenex to Present Pivotal Data in T315I Positive CML Patients as Oral Presentation at ASCONASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
09/04/200912:00Business WireChemGenex Completes Capital Raising, Announces Rights IssueNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
26/03/200911:40Business WireNew Data Suggesting that ChemGenex’s Omacetaxine Can Eradicate Leukemic Stem Cells May Offer a Breakthrough in Treating CMLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
30/12/200820:00Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
16/06/200821:04Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/04/200814:00Business WireChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia PatientsNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
27/11/200723:25Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/10/200716:41Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd (Other) (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
11/06/200722:30Business WireChemGenex Announces Publication Confirming Activity of Ceflatonin(R) in T315I-Positive CMLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
03/04/200704:27Business WireChemGenex Announces the Completion of A$21 Million FinancingNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
05/01/200718:08Business WireChemGenex Pharmaceuticals: Announcement Pursuant To Nasdaq Marketplace Rule 4350(b)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
04/04/200614:00PR Newswire (US)Preclinical Progress Reported at American Association of Cancer Research ConferenceNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
23/03/200600:26PR Newswire (US)New Preclinical Research Supports Ceflatonin(R) in Treatment of Acute Myeloid Leukemia (AML)NASDAQ:CXSP
20/03/200605:40PR Newswire (US)Orphan Drug Designation Granted by the U.S. FDA for Ceflatonin(R)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
06/03/200600:00PR Newswire (US)Cowen & Co. 26th Annual Health Care Conference to Webcast ChemGenex PresentationNASDAQ:CXSP
18/01/200601:12PR Newswire (US)ChemGenex Granted U.S. Patent on Ceflatonin(R)'s Use for Treatment of Gleevec(R)-Resistant Patients With CML and Ph-Positive ALLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
17/01/200614:20PR Newswire (US)New Diabetes Research Contract With Merck KGaANASDAQ:CXSP
12/12/200500:00PR Newswire (US)ChemGenex Reports Compelling Phase 2 Data Published In Leading Leukemia JournalNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
08/11/200502:47PR Newswire (US)ChemGenex to Present at Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceNASDAQ:CXSP
09/10/200520:00PR Newswire (US)Scientists Pinpoint Inflammation GeneNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
27/09/200503:35PR Newswire (US)ChemGenex Personalized Medicine Clinical Trial Expanded to Patients with Breast and Ovarian CancersNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
30/08/200518:14PR Newswire (US)2004-05 Financial Report Highlights Successful Year for ChemGenexNASDAQ:CXSP
04/08/200515:12PR Newswire (US)ChemGenex Joins New NASDAQ Health Care IndexNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
28/06/200502:00PR Newswire (US)ChemGenex and Stragen Pharma Create Alliance to Accelerate Clinical Development and Commercialization of Ceflatonin(R)NASDAQ:CXSP
27/06/200519:57PR Newswire (US)ChemGenex to List On Nasdaq (Nasdaq SC: CXSP)NASDAQ:CXSP
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CXSP

La tua Cronologia

BIT
P221D1
NLBNPIT221D1 20991231 6....
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network